Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05968885 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 9, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Dec 31, 2024 to Jun 30, 2026
    • Study completion date: Jun 30, 2025 to Dec 31, 2026
    v3
  2. Study Identification, Study Status, Sponsor/Collaborators, Oversightv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To investigates the effects of botulinum toxin type A bladder injection compared to combined pharmacotherapy with Mirabegron and Solifenacin.
Trial Details
NCT Number NCT05968885
Lead Sponsor Mackay Memorial Hospital
Conditions
(from sponsor)		 Urinary Bladder, Overactive, Urodynamics, Effect of Drug
Related terms Urinary Bladder, Overactive
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov